Trial intelligence / Profile preview

Long-term Genotropin in short children born small for gestational age (SGA)

2015-004552-21Phase 4

Sponsor
Pfizer
Start
May 2016
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of somatropin in Small for gestational age (SGA), sponsored by Pfizer. Primary endpoint: Safety (laboratory parameters and adverse events).

02

Drugs

somatropin
03

Conditions

Small for gestational age (SGA)

Beyond the preview

Go deeper on 2015-004552-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-004552-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call